Sebi rejects Anil Ambani’s Reliance Infra settlement application

India’s market regulator has rejected Anil Ambani’s settlement bids concerning allegations of misusing nearly $700 million in company funds. The Securities and Exchange Board of India cited parallel investigations by other agencies, stating the transactions could be for personal enrichment. This marks the second settlement rejection for Ambani, with the group categorically denying the claims.

Sebi rejects Anil Ambani’s settlement request over Reliance Infrastructure

India’s market regulator has rejected Anil Ambani’s settlement bids concerning allegations of misusing nearly $700 million in company funds. The Securities and Exchange Board of India cited parallel investigations by other agencies, stating the transactions could be for personal enrichment. This marks the second settlement rejection for Ambani, with the group categorically denying the claims.

Beyond Valuations: Philip Fisher’s timeless guide to quality stock investing

Legendary investor Philip Fisher championed a qualitative approach to stock picking, emphasizing exceptional businesses with strong management and durable competitive advantages. His 15-point checklist, still relevant today, guides investors to look beyond numbers, focusing on long-term growth potential, innovation, financial strength, and, crucially, management integrity. Fisher’s philosophy stresses that identifying outstanding companies and holding them…

Healthcare demand is outstripping supply in Noida, says MOFSL; prefers Medanta, Max Healthcare

Noida-Greater Noida is rapidly becoming a prime healthcare hub in North India, fueled by population growth and corporate expansion. Despite increasing capacity, the region faces a significant shortage of super-specialty beds. Strong demand for various medical services is evident, with hospitals experiencing rising occupancy and robust revenue. Infrastructure development further bolsters the market’s long-term potential,…